Document:

Exhibit 10.9

 

New Hire Authorization—Updated Appendix

 

Stock
options covering an aggregate of 7,000 shares of common stock were granted to
two non-executive officer employees on February 3, 2006 under the Company’s New
Hire Authorization as an inducement to entering into employment with the
Company. The options include a ten-year duration and an exercise price equal to
the closing price of Dendrite’s stock on the business day immediately preceding
the date of grant. The vesting schedule for the options is as follows:  (i) twenty-five percent (25%) of the options
shall first become exercisable on the first anniversary of date of grant and
(ii) the remaining seventy-five percent (75%) shall become exercisable pro rata
over the following three (3) year period, on a monthly basis, commencing on the
first anniversary of the date of grant and ending on the fourth anniversary of
the date of grant.EXECUTION

AMENDMENT NO. 4 TO

NOTE PURCHASE AGREEMENT

THIS AMENDMENT NO. 4 (the “Amendment”),
dated as of February 23, 2006, is by and between INTERLEUKIN GENETICS,
INC., a Delaware corporation (the “Company”), and
PYXIS INNOVATIONS INC., a Delaware corporation (“Pyxis”).

The Company and Pyxis are parties to a Note Purchase Agreement dated as
of October 23, 2002, as amended November 13, 2002, January 28,
2003, and March 5, 2003 (the “Agreement”). Capitalized
terms not otherwise defined in this Amendment shall have the meanings given to
them in the Agreement.

The parties agree as
follows:

1.                                       Recital C of the Agreement is revised to
reflect the following developments since the Initial Closing:

Pyxis has purchased, and the Company has sold and
issued to Pyxis, a promissory note in a principal amount of $500,000 on each of
the following dates: October 23, 2002, November 14, 2002, December 16,
2002, and January 28, 2003 (the “Existing Notes”).

On March 5, 2003, the
Company and Pyxis entered into Stock Purchase Agreement (the “Stock Purchase Agreement”) and various agreements referenced
therein (collectively, the “Affiliation Agreements”).
Pursuant to Section 2.5 of the Stock Purchase Agreement, Pyxis (i) has
agreed to extend further credit to the Company to expand its research
partnerships (the “Research Loans”),
and (ii) refinanced the Company’s bridge financing loans previously due in
August 2003 (the “Refinancing Loan”).
In addition, pursuant to Section 2.6 of the Stock Purchase Agreement, the
Company and Pyxis amended and restated the terms of the Existing Notes.

On March 5, 2005, the
Company and Pyxis amended the Stock Purchase Agreement to extend until March 5,
2007 the period during which Pyxis agrees to purchase additional Notes pursuant
to Section 2.2B of this Agreement (Research Loans), subject to the terms
and conditions of this Agreement.

2.                                       The following new Sections shall be added
immediately following Section 2.2D of the Agreement:

2.2E                Working
Capital Loans. At any time prior to April 1, 2007, Pyxis hereby
agrees to purchase, and the Company hereby agrees to sell and issue to Pyxis,
one or more Notes, the aggregate principal amount of which shall not exceed
$2,000,000 (each, a “Working Capital Loan”).
Subject to the terms and conditions of this Agreement, the closing of these
purchases (each, a “Subsequent Closing”)
will take place within ten business days following the Company’s written
request to Pyxis to make such loan. For the purposes of each Working Capital
Loan: (a) Pyxis hereby waives each of the closing conditions set forth in Section 2.5
except Section 2.5.3 (Injunction), Section 2.5.8 (Event of

 

Default), and Section 2.5.12
(Other Documents); and (b) the Company hereby waives each of the closing
conditions set forth in Section 2.4 except Section 2.4.3
(Injunction).

2.2F                Form of
Note. The Note for each Working Capital Loan shall be in a form
substantially similar to the form of the Existing Notes; provided (a) the
term of the Note shall be five years from the date of issuance, (b) interest
shall be prime plus 1%, paid quarterly; and (c) the sections entitled “Conversion”
and “Amends and Restates” shall be excluded.

3.                                       Section 2.5.1 of the Stock Purchase
Agreement and Sections 2.2B and 5.1 of the Agreement are each hereby amended to
(a) remove the requirement that the Research Loans be used only for
specific purposes, and (b) permit the Research Loans to be used for
general working capital purposes.

4.                                       Except as amended hereby, all of the terms
and conditions of the Agreement shall remain in full force and effect. This
Amendment shall be binding upon and inure to the benefit of the parties hereto
and their respective successors and assigns.

This Amendment No. 4 to Note Purchase Agreement is signed as of
the date first written above.

	
  

  	
  INTERLEUKIN GENETICS, INC

  
	
   

  	
   

  
	
   

  	
  By

  	
  /s/  PHILIP R. REILLY

  
	
   

  	
   

  	
   

  
	
   

  	
  Its:

  	
  CEO

  
	
   

  	
   

  	
  PYXIS INNOVATIONS INC.

  
	
   

  	
   

  	
   

  
	
   

  	
  By

  	
  /s/  KIM S. MITCHELL

  
	
   

  	
   

  	
  Kim S. Mitchell

  
	
   

  	
  Its:

  	
  Assistant Secretary

  

 

 2CONFIDENTIAL
MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMISSION. ASTERISKS DENOTE OMISSIONS.

Exhibit 10.2

PURCHASE AGREEMENT

THIS PURCHASE
AGREEMENT (the “Agreement”) is made effective as
of January 31, 2006, (the “Effective Date”) between ACCESS
BUSINESS GROUP INTERNATIONAL LLC, acting as agent for ACCESS BUSINESS GROUP LLC
(“Access”), a Michigan limited liability
company, having its principal office at 7575 East Fulton Road, Ada, Michigan
49355, United States; and INTERLEUKIN GENETICS, INC.,
a Delaware corporation having its principal office at 135 Beaver Street,
Waltham, MA 02453 (“Seller”). Access
and Seller may also be referred to separately as a “party”
and collectively as “parties.”

RECITALS

Seller is engaged
in the business of providing genetic testing services and has indicated its
willingness to act as supplier of the Services (defined in Section 1(a),
below) to Access for resale to Quixtar Inc., an Affiliate of Access, which will
then sell the Services to end-users, as well as kits to be used for collection
of genetic material from end-users (“Collection Kits”).

The parties wish
to enter into this Agreement to set forth the terms of Seller’s supply of the
Services.

For purposes of
this Agreement, “Affiliate” means, with respect to
the applicable party, any corporation, company, partnership, trust, sole
proprietorship or other entity or individual which: (a) is owned or
controlled by such party, in whole or in part; (b) owns or controls such
party, in whole or in part; or (c) is under common ownership or control
with such party, in whole or in part; provided that for the purposes of this
Agreement, Seller shall not be deemed an Affiliate of Access or its Affiliates.

AGREEMENT

NOW, THEREFORE, in
consideration of the mutual covenants and commitments set forth in this
Agreement, the parties agree as follows:

1.             Definition of and
Specifications for Services.

(a)           Service(s). As
used in this Agreement, the term “Service” or “Services” shall mean the genetic testing services listed on Exhibit A, which is attached to and made part of this
Agreement, the provision of a report prepared by Seller in accordance with CLIA
requirements (a “Report”), to end-users, a sample
copy of which is included in Exhibit A,
as well as any genetic counseling services provided by Seller to end-users
regarding such Services.

(b)           Specifications.
As used in this Agreement, the term “Specifications”
shall mean those specifications for the Services that are set forth in Exhibit A, which is attached to and made part of this
Agreement.

 

(c)           Changes to Specifications.
Either of the parties may from time to time request modifications or additions
to the Specifications, provided, however, that such modifications or additions
are approved by both parties in writing or by electronic mail. Seller shall
provide Access with such information as Access may reasonably request from time
to time to determine the price of the Services due to a prospective change in
the Specifications. Notwithstanding the foregoing, Seller reserves the right to
keep certain of its information regarding costs confidential.

2.             Purchase and
Sale of Services.

(a)           General. During
the term of this Agreement, Access shall purchase Services exclusively from
Seller and Seller shall sell the Services to Access, all in accordance with the
terms of this Agreement. Access is under no obligation to order any minimum
quantity of Services.

(b)           Invoices. Seller
will submit invoices for charges related to the Services on a monthly basis to
the address set forth above. Each undisputed invoice shall be due and payable
within thirty (30) days of the receipt of a properly payable invoice.

(c)           Location for Performing
the Services. Seller shall perform the Services at Seller’s clinical
laboratory located in Waltham, Massachusetts. Except as provided herein, Seller
shall not subcontract part or all of the performance of the Services to any
other person or entity without Access’s prior written consent, which shall not
be unreasonably withheld. Access agrees and acknowledges that, at certain
volumes, Seller may subcontract the Services to other laboratories (“Reference Labs”), provided that any such Reference Lab meet
required certifications under the Clinical Laboratory Improvement Act of 1988,
as amended (“CLIA”), and Seller provides such
documentation to Access at least thirty (30) days prior to the effectiveness of
any subcontract. Seller shall not change or modify part or all of the provision
of the Services without Access’s prior written consent.

3.             Prices.

(a)           General. The
price to be paid by Access for Services described in this Agreement are set
forth in Exhibit B to this Agreement, which
is attached and made part of this Agreement. Such price is exclusive of
value-added, sales or other applicable taxes. Except as provided in Sections 1(c) and
3(b), the price for the Services set forth in Exhibit B
is firm during the initial two year term of this Agreement and may not be
increased by Seller for any reason during the initial two year term of this
Agreement.

(b)           Modifications to Pricing.
Notwithstanding Section 3(a), Seller may increase the price to be charged
for the Services at any time to cover any additional expenses incurred by
Seller as a result of modifications to the Specifications agreed upon by the
parties. Seller will provide to Access reasonable documentary evidence of such
changes in price on request. Seller shall give ninety (90) days’ prior written
notice of any price increase allowed hereunder. Access will confirm its
approval of such changed costs in writing to Seller prior to 

 2
 

 

implementation thereof. Price
changes allowed under this Section 3(b) shall not be applicable to
Services that have already been performed, unless otherwise agreed in writing
by the parties.

(c)           Audit. Seller
shall keep accurate books, records and systems under an accounting system
maintained in accordance with the Generally Accepted Accounting Principles
(GAAP) consistently applied so as to ensure the capability of a proper audit of
the price of the Services. Upon at least 30 days’ prior written request, and in
no case more than twice per calendar year, Access or Access’ authorized
auditor, such authorized auditor to be reasonably acceptable to Seller, shall
have reasonable access during Seller’s customary business hours to such books,
records and systems for the purpose of inspecting and examining the same to
confirm compliance with the terms of this Agreement. Any audit expense will be
borne by Access, except in the event that any audit reveals a discrepancy
greater than 10% in Access’ favor, in which case Seller shall bear the expense
of such audit.

4.             Payment.

(a)           Payment. Access
shall pay Seller’s invoice for the Services within 30 days of the date of
Seller’s invoice.

(b)           Services that do not
comply with Specifications. If Access determines that any of the
Services do not comply with the Specifications, or the other requirements of
this Agreement (including the warranties set forth in Section 6) or in any
respect that prevents Access from reselling such Services, then:

(i)            Access shall give Seller a notice
identifying such Services, and the grounds for the noncompliance;

(ii)           (A) Notwithstanding Section 4(a) above,
if payment has been made by Access for those noncomplying Services, Access
shall be entitled either to be reimbursed by Seller’s payment to Access of the
appropriate amount or to a credit of the appropriate amount against any amounts
then or subsequently payable by Access to Seller hereunder, and/or (B) Seller
shall, if required by Access after receipt of such notice, use its best efforts
to deliver to Access as soon as possible, and otherwise in accordance with the
provisions of this Agreement, replacement Services, requested by Access but not
exceeding the number of noncomplying Services.

5.             Representations and
Warranties.

(a)           General. Seller
represents and warrants to Access that (a) it shall have and maintain
necessary qualifications, expertise, authority, registrations, licenses, and
permits to enable it to perform its obligations under and contemplated by this
Agreement, including CLIA registration for its laboratory where the Services
are performed; (b) the Services and Reports included in connection
therewith shall be performed in a professional manner in accordance with
industry standards, free from material faults and defects; (c) the
Services shall conform in all material respects to all  specifications and performance criteria
standards or other requirements that are set forth on Exhibit A
or otherwise agreed upon by Seller and Access; (d) the Services 

 3
 

 

shall comply with all
applicable (U.S. and Canadian) federal, state, provincial and local laws and
regulations; (e) to the knowledge of Seller, (i) Seller is the owner
of all right, title and interest in and to, or otherwise holds a license under,
the intellectual property associated with the 
Services and (ii) its performance of the Services contemplated by
this Agreement does not infringe the patent rights of any third party; (f) Seller
shall supervise the Reference Labs to the extent necessary to provide quality assurance
of the Services  at the same level as
provided at Seller’s own facility; (g) all information supplied by Seller
to Access on or before the date of this Agreement was when furnished, and is as
of the date of this Agreement, true, correct and complete in all material
respects and that it will promptly notify Access if any such information
changes materially during the term of this Agreement; (h) Seller has and
will maintain sufficient capacity to satisfy Access’s requirements for the
Services during the term of this Agreement based on the volume estimates
provided by Access to Seller as of the Effective Date; and (i) Seller will
comply with, and shall take no action which subjects Access to risk of
noncompliance with, all applicable laws and regulations, including without
limitation the U.S. Foreign Corrupt Practices Act and all laws and regulations
regarding Seller’s working conditions for its employees during the term of this
Agreement.. Seller has and follows, and will continue to have and follow, adequate
quality and security procedures that will assure that the Services will comply
with the foregoing representations and warranties. Upon written request, Seller
shall give Access an officer’s certificate of compliance with respect to
applicable laws and regulations. Access’ approval of any specification or other
standards shall not relieve Seller of any of its warranties under this Section.
Seller’s warranties extend to future performance of the Services and survive
acceptance and payment. Seller shall extend to all end-users to which it
provides Reports the warranty set forth on Exhibit C
attached hereto and incorporated herein by reference (the “End-User
Warranty”).

(b)           Seller’s
Agreements Regarding Website.
Seller will maintain a website adequate for end users to obtain Reports on a
publishing server and shall take commercially reasonable security precautions
to prevent unauthorized access thereto. Seller will provide reasonable and
customary backups to its publishing server and maintain and store backup tapes.
Seller will perform restorations to its publishing server in the event of a
service failure. Seller will respond to Access’ requests for restoring files
within 3 business days. Seller will provide Access with a copy of Seller’s
privacy policy. Seller shall not collect, store or use any End-User Information
(as defined herein) not voluntarily provided by such end-user. Seller shall not
disclose any End-User Information of any kind to any third party without
valid legal process and only in compliance with all applicable laws. Seller
shall not send any literature or solicitation materials targeted specifically
to end-users or specifically solicit end-users for any products or services not
offered through this Agreement. “End-User Information”
means all: (a) navigational information relating to an end-user, including
but not limited to usage of other hyperlinks within or available through Seller’s
Website; and (b) information relating to an end-user including, but not
limited to, Internet address and/or other identifying information such as
actual name or address.

6.             Access to Facilities.
During the term of this Agreement, Access may designate one or more Access
employees or other persons who shall be allowed to visit Seller’s laboratory
during Seller’s customary business hours for the purposes of inspecting Seller’s
processes for provision of the Services by Seller.  In order to prevent interference with
laboratory operations, Access shall obtain written authorization from Seller
prior to any such inspection.

 4
 

 

7.             Term and
Termination.

(a)           General Term. The
initial term of this Agreement shall commence on the Effective Date of this
Agreement and shall continue for two years thereafter. This Agreement may be
renewed from year-to-year after the initial term upon written agreement of the
parties.

(b)           Termination Upon Default.
At any time during the term of this Agreement, either party may terminate this
Agreement by written notice to the other party if the other party is in
material default in the performance of any of its obligations hereunder and
fails to remedy such default within thirty (30) days after receiving written
notice of such default.

(c)           Termination by Either
Party for Cause. Either party may immediately terminate this
Agreement by written notice to the other:

(i)            If the other party has ceased its
business activities or has otherwise begun winding up its business affairs;

(ii)           If bankruptcy, reorganization,
arrangement or insolvency proceedings, or other proceedings for relief under
any bankruptcy or similar law or laws for the relief of debtors, are instituted
by or against the other party and are consented to or are not dismissed within
sixty (60) days after such institution;

(iii)          If a custodian, liquidator, receiver
or trustee is appointed for the other party or the major part of its property
and is not discharged within sixty (60) days after such appointment;

(iv)          If the other party becomes insolvent
or bankrupt, is generally not paying its debts as they become due, makes any
assignment for the benefit of its creditors or makes any comparable arrangement
with its creditors; or

(v)           Upon the occurrence of any Force
Majeure Event (defined below) that delays or is anticipated to delay
performance of the other party of this Agreement for more than thirty (30)
days.

(d)           Additional Termination by
Access for Cause. Except as set forth in Section 12, Access may
immediately terminate this Agreement for Seller’s inability for any reason to
meet Access’s request for Services for a period exceeding 30 days beyond
receipt by Seller of a Collection Kit from an end-user or failure to meet the
Specifications for the Services at any time.

(e)           Survival of Certain
Provisions. The termination of this Agreement shall not affect any
of the provisions of this Agreement that by their nature are intended to
continue after termination, including but not limited to Section 5
(Representations and Warranties), Section 7 (Term and Termination), Section 8
(Confidential Information) and Section 10 (Indemnification).

 5
 

 

(f)            Liability for Termination.
Access in exercising its rights to terminate this Agreement in accordance with
the terms and conditions hereof shall not incur any liability whatsoever for
any damage, loss or expense of any kind suffered or incurred by Seller (or for
any compensation to Seller) arising from or incident to any such termination,
expiration or non-renewal. Any termination hereof shall not impair any rights
nor discharge any obligations which have accrued to Access as of the effective
date of such termination.

8.             Confidential
Information.

(a)           Confidentiality
Obligations. During the term of this Agreement and at all times
thereafter, Seller agrees to hold in confidence and not otherwise use or
disclose the information of Access and its Affiliates, including without
limitation, any information relating to Access’ and its Affiliates’ business
operations, price lists, manufacturing data, marketing information strategies,
customer or product lists, research and development information and all other
information disclosed by Access or its Affiliates to Seller (“Confidential
Information”), in confidence and not to use any of the foregoing commercially
for its own benefit or that of any other party, nor for the purpose of
developing or improving a product or method for any other party except Access. Seller
agrees to limit dissemination of and access to the Services and/or
Specifications or such information only to the persons within Seller’s
organization, performing Services under this Agreement, and then only to those persons
who have a need for access thereto, and who have entered into a restrictive
agreement prohibiting such personnel from doing anything with respect to the
Services and/or Specifications and such information that Seller would itself be
prohibited from doing under this Agreement. Notwithstanding the foregoing,
should Seller wish to disclose to third parties such as agents or
subcontractors Confidential Information, Seller must, before making such
disclosure, obtain the prior written approval of Access and, if such approval
is provided, obtain from the third party to whom the disclosure will be made a
confidentiality agreement that is at least as restrictive as the provisions of
this Section 8. The confidentiality obligations within this Section 8
shall survive termination or expiration of this Agreement for a period of three
(3) years from the date of termination of this Agreement and deemed to
cover all Confidential Information provided pursuant to this transaction. Should
either Seller or Access disclose to third parties such as agents or
subcontractors confidential information belonging to the other party to this
Agreement, the disclosing party must, before making such disclosure, notify the
other party of this Agreement that the disclosure will be made and obtain from
the third party to whom the disclosure will be made a confidentiality agreement
similar to the terms hereof. The parties acknowledge that all confidential
information of the other party shall be owned solely by the other party, and
each party agrees to return all items containing confidential information to
the other party as requested upon termination of this Agreement. Seller and
Access recognize and agree that nothing contained in this Agreement shall be
construed as granting any rights, by license or otherwise, to any confidential
information disclosed pursuant to this Agreement.

(b)           Limitation on Obligations. The obligations specified in Section 8(a) above
shall not apply with respect to any information, which Seller can establish by
written records:

 6
 

 

 

i.                                          was
already in Seller’s possession prior to disclosure hereunder and is not
protected by confidentiality provisions of any other agreement between Access
and Seller;

ii.                                       is
or becomes available to the public through no wrongful act of Seller;

iii.                                    is
disclosed, without restriction on further disclosure, to Seller by a third
party having no duty of confidentiality with respect to such information
whether to Seller or to another party, and having the legal right to disclose
such information; or,

iv.                                   has
been developed by or for Seller independently by person(s) having no
access to the Confidential Information.

(c)           Legally Required
Disclosures. If Seller is required under applicable law to disclose
the Specifications for the Services, or any other Confidential Information, to
any governmental or regulatory agency or pursuant to any court order or
subpoena, it shall do so only after giving prompt notice to that effect to
Access so that Access may review the scope of any such disclosure and, in the
case of any legal or regulatory proceeding, Access may seek to prevent such
disclosure or production or, if that cannot be achieved, the entry of a
protective order or other appropriate device or procedure. If Seller is
unsuccessful in seeking a protective order or other remedy satisfactory to
Access, Seller shall disclose only that portion of the Confidential Information
as to which Seller is advised by independent legal counsel is legally required
to be disclosed or furnished (with a copy of a written opinion of such counsel
to that effect to be simultaneously furnished to Access).

10.           Indemnification.

(a)           Indemnification by Seller.
Seller shall defend, indemnify and hold Access (including its Affiliates,
members, managers, directors, officers, employees, and agents) harmless from
and against any damages, claims, costs and expenses (including actual attorneys’
fees and recall costs and expenses) arising from or relating to (i) any
breach or misrepresentation by Seller under this Agreement, or (ii) any claim
by an end-user of the Services, including any breach of the End-User Warranty
that is a result of Seller’s performance of the Services described herein.

(b)           Indemnification by Access.
Access shall defend, indemnify and hold Seller (including its members,
managers, directors, officers, employees, agents and end-users) harmless from
and against any damages, claims, costs and expenses (including actual attorneys’
fees and recall expenses) arising from or relating to (i) any breach or
misrepresentation by Access under this Agreement, or (ii) the manufacture,
use or sale by Access, or the use by an end-user, of any collection kit
necessary for the performance of the Services.

(c)           Procedures. If
any action, suit, proceeding or claim shall be commenced in respect of which a
party may demand indemnification, the indemnified party shall notify the 

 7
 

 

indemnifying party to
that effect with reasonable promptness. The indemnifying party shall have the
opportunity to defend against such action, suit, proceeding or claim. The
indemnified party shall have the right to employ its own counsel and
participate in the defense of any matter at its own expense. If the
indemnifying party fails to defend as required hereunder, the indemnified party
may defend itself at the indemnifying party’s expense. Each party shall render
to the other assistance as may be reasonably required in connection with the
defense of any such matter.

(d)           Recall of Collection Kits.
If the Collection Kits constitute a health or safety hazard or risk, or if the
Collection Kits or their distribution becomes the subject of heightened
governmental regulation, then Access shall have the right to recall such
Collection Kits at its sole expense; provided, that, if the reason for the
recall is the inability to perform the Services, as currently anticipated,
without violating applicable law, then Seller shall pay the reasonable costs of
such recall.

11.           Insurance. Seller
shall maintain in effect at all times during the term of this Agreement
insurance, from an insurance company reasonably acceptable to Access, of the
types and in the amounts set forth below protecting against losses, claims,
demands, proceedings, damages, costs, charges and expenses for injuries
(including death) or damage to person or property arising out of the sale of
the Services to the extent such injuries or damage are due to the fault or
negligence of Seller or its agents or subcontractors:

Professional
Liability                                           U.S.       $ 1,000,000 (per occurrence)

Seller further
agrees to furnish to Access, concurrently with the execution of this Agreement,
insurance certificates which will confirm its insurance coverage in the amounts
referenced above, to arrange for its liability insurance carriers to include
Access and its Affiliates as additional insureds under its standard vendor’s
product liability insurance policy and to arrange for its insurance carriers to
include as part of all such certificates the requirement to furnish thirty (30)
days advance written notice to Access of any material change in, or
cancellation or termination of, such insurance policies.

12.             Force Majeure.
Subject to the other provisions of this Agreement, in the event that either
party is unable to perform any of its obligations under this Agreement because
of natural disaster, actions or decrees of governmental bodies or events or
causes beyond the control of the affected party (a “Force
Majeure Event”) all obligations of the affected party under this
Agreement shall be immediately suspended, provided that such affected party
promptly gives the other party notice of the occurrence of the Force Majeure
Event. The affected party shall make its best efforts to eliminate the
obstacles preventing its performance and to resume its performance under the
Agreement as soon as possible. Under no circumstances shall any delay or
failure to perform as a result of a labor dispute or strike be interpreted to
be a Force Majeure Event.

13.           Miscellaneous
Provisions.

(a)           Assignment. Neither
party shall assign, transfer or subcontract this Agreement or any part of this
Agreement, directly or indirectly, without the other party’s prior 

 8
 

 

written consent; provided, however, that Access may assign its rights and
obligations under this Agreement to any Affiliate of Access without the prior
written consent of Seller, in which case Access shall not be released from any
of its obligations, financial or otherwise, under this Agreement and Seller may
assign its rights and obligations hereunder to any person or entity that
succeeds to all or substantially all of Seller’s business or that aspect of
Seller’s business that is the subject of this Agreement. This Agreement shall
be binding upon, inure to the benefit of, and be enforceable by and against the
respective successors and permitted assigns of each of the parties to this
Agreement. The Affiliates of Access shall have the right to specifically
enforce this Agreement and are intended third parties beneficiaries of this
Agreement.

(b)           Notices. All
notices and other communications under this Agreement shall be in the English
language, in writing and shall be deemed to have been duly given when either
personally delivered, or sent by facsimile or sent by express delivery service
with charges prepaid and receipt requested, or, when mailed (postage prepaid)
by certified mail with return receipt requested, to the parties at their
respective addresses set forth below. Any party may change its address by
written notice to the other party.

Access Business Group International LLC

7575 Fulton Street East

Ada, Michigan 49355

Attn:  Strategic Procurement

Interleukin Genetics, Inc.

135 Beaver Street — 2nd floor

Waltham, Massachusetts 03452

Attn: Chief Financial Officer

(c)           Entire Agreement;
Amendments. This Agreement contains the entire agreement of the
parties and replaces all prior agreements and understandings. This Agreement
may be amended, modified, superseded, or canceled and any of the terms or
conditions in this Agreement may be waived, only by a written instrument signed
by each party to this Agreement or, in the case of a waiver, by or on behalf of
the party waiving compliance. The failure of any party at any time to require
performance of any provision in this Agreement shall not affect the right at a
later time to enforce that or any other provision. No waiver by any party of
any condition, or of any breach of any term contained in this Agreement, in any
one or more instances, shall be deemed to be a further or continuing waiver of
that or any other condition or breach. No course of dealing between the parties
or usage of trade shall be effective to amend, supplement, modify, or otherwise
alter, in whole or in part, the express terms of this Agreement.

(d)           Severability. This
Agreement shall be interpreted in all respects as if any invalid or
unenforceable provision were omitted from this Agreement. All provisions of
this Agreement shall be enforced to the full extent permitted by law.

(e)           No Agency. This Agreement does not in any way create the
relationship of principal and agent, employer and employee, partner or joint venture
between Seller and Access. Under no circumstances shall Seller or its employees
be considered to be the agents or 

 9
 

 

employees of Access, or
vice versa. Neither Seller nor Access shall (a) act or attempt to act or
represent itself directly or by implication, as agent or employee of the other
or in any manner, (b) assume or create or attempt to assume or create, any
obligation on behalf of or in the name of the other, or (c) make any
representations, guarantees, or warranties on behalf of or in the name of the
other with respect to any matter.

(f)            Governing Law; Venue.
This Agreement shall be governed by and shall be construed in accordance with
the internal laws of the State of Michigan, without regard to conflicts of law
principles and without regard to the United Nations Convention on Contracts for
the International Sale of Goods (the “CISG”). The
parties agree that the CISG shall not apply to this Agreement. Each party (i) agrees
that any litigation arising out of this Agreement may be brought only in the
state or federal courts whose jurisdiction includes Kent County, Michigan, (ii) consents
to the jurisdiction of such courts, and (iii) waives any argument that any
such court is an inconvenient forum.

(g)           Counterparts. This
Agreement may be executed in one or more counterparts, each of which will be
deemed to be an original copy of this Agreement and all of which, when taken
together, will be deemed to constitute one and the same Agreement. A facsimile
copy of the signed Agreement will be deemed to be an original of this Agreement
for purposes of execution by counterparts.

(h)           Headings. The
section headings contained in this Agreement are solely for the purpose of
reference, are not part of the agreement of the parties and shall not in any
way affect the meaning or interpretation of this Agreement.

IN WITNESS
WHEREOF, the parties have entered into this Agreement as of the date first set
forth above.

	
  ACCESS BUSINESS GROUP

  	
   

  	
   

  	
  INTERLEUKIN GENETICS, INC.

  
	
  INTERNATIONAL LLC, acting as agent

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  for ACCESS BUSINESS GROUP LLC

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  By: 

  	
   

  	
  /s/ Jay G. Ertl

  	
   

  	
   

  	
  By:

  	
   

  	
   

  	
  /s/ Philip R. Reilly

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Print Name: 

  	
  Jay G. Ertl

  	
   

  	
   

  	
  Print Name: 

  	
  Philip R. Reilly, MD, JD

  
	
  Its: 

  	
   

  	
  Vice President - Product Supply

  	
   

  	
   

  	
  Its:

  	
   

  	
   

  	
  Chief Executive Officer

  
	
   

  	
  “Access”

  	
   

  	
   

  	
   

  	
  “Seller”

  
																			

 

 10
 

 

Exhibit A

*****

 11
 

 

Exhibit B

*****

 12
 

 

Exhibit C

 End-User Warranty:  Seller expressly warrants to end-users of the
Services that (a) the Services and Reports included in connection
therewith shall be performed in a professional manner in accordance with
industry standards, free from material faults and defects; (b) the
Services shall conform in all material respects to all  specifications and performance criteria
standards or other requirements that are set forth on Exhibit A
or otherwise agreed upon by Seller and Access; and (c) the Services shall
comply with all applicable (U.S. and Canadian) federal, state, provincial and
local laws and regulations.

 13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}]]